Malnique F, Garcia T de A, Ferreira DM, Barletta AAB, Silvino R dos S, Souza e Silva PH, et al. USE OF DAPAGLIFLOZIN (FORXIGA) IN THE MANAGEMENT OF OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES. Editora [Internet]. 2025 Nov. 18 [cited 2025 Nov. 21];:368-79. Available from: https://sevenpubl.com.br/editora/article/view/8517